BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 8992027)

  • 1. Pharmacokinetics of marbofloxacin in dogs after oral and parenteral administration.
    Schneider M; Thomas V; Boisrame B; Deleforge J
    J Vet Pharmacol Ther; 1996 Feb; 19(1):56-61. PubMed ID: 8992027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of marbofloxacin in mature horses after single intravenous and intramuscular administration.
    Carretero M; Rodríguez C; San Andrés MI; Forés P; de Lucas JJ; Nieto J; Waxman S; San Andrés MD; González F
    Equine Vet J; 2002 Jul; 34(4):360-5. PubMed ID: 12117107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic behavior of marbofloxacin after intravenous and intramuscular administrations in adult goats.
    Waxman S; Rodríguez C; González F; De Vicente ML; San Andrés MI; San Andrés MD
    J Vet Pharmacol Ther; 2001 Dec; 24(6):375-8. PubMed ID: 11903866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic characteristics and tissue residues for marbofloxacin and its metabolite N-desmethyl-marbofloxacin in broiler chickens.
    Anadón A; Martínez-Larrañaga MR; Díaz MJ; Martínez MA; Frejo MT; Martínez M; Tafur M; Castellano VJ
    Am J Vet Res; 2002 Jul; 63(7):927-33. PubMed ID: 12118670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of marbofloxacin in horses.
    Bousquet-Melou A; Bernard S; Schneider M; Toutain PL
    Equine Vet J; 2002 Jul; 34(4):366-72. PubMed ID: 12117108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin after intravenous and oral administration of enrofloxacin in dogs.
    Küng K; Riond JL; Wanner M
    J Vet Pharmacol Ther; 1993 Dec; 16(4):462-8. PubMed ID: 8126763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of fluoroquinolone pharmacokinetic parameters after treatment with marbofloxacin, enrofloxacin, and difloxacin in dogs.
    Frazier DL; Thompson L; Trettien A; Evans EI
    J Vet Pharmacol Ther; 2000 Oct; 23(5):293-302. PubMed ID: 11107003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of experimental renal impairment on disposition of marbofloxacin and its metabolites in the dog.
    Lefebvre HP; Schneider M; Dupouy V; Laroute V; Costes G; Delesalle L; Toutain PL
    J Vet Pharmacol Ther; 1998 Dec; 21(6):453-61. PubMed ID: 9885968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacokinetic/pharmacodynamic integration of marbofloxacin in calf serum, exudate and transudate.
    Aliabadi FS; Lees P
    J Vet Pharmacol Ther; 2002 Jun; 25(3):161-74. PubMed ID: 12081611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary single-dose pharmacokinetics of marbofloxacin in ball pythons (Python regius).
    Coke RL; Isaza R; Koch DE; Pellerin MA; Hunter RP
    J Zoo Wildl Med; 2006 Mar; 37(1):6-10. PubMed ID: 17312805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacokinetics of baytril (enrofloxacin) in dogs].
    Küng K; Wanner M
    Schweiz Arch Tierheilkd; 1994; 136(10):329-34. PubMed ID: 7801085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and comparison of marbofloxacin metabolites from the plasma of ball pythons (Python regius) and blue and gold macaws (Ara ararauna).
    Hunter RP; Koch DE; Coke RL; Carpenter JW; Isaza R
    J Vet Pharmacol Ther; 2007 Jun; 30(3):257-62. PubMed ID: 17472658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetics of marbofloxacin in aqueous humor after intravenous administration in dogs.
    Regnier A; Concordet D; Schneider M; Boisramé B; Toutain PL
    Am J Vet Res; 2003 Jul; 64(7):889-93. PubMed ID: 12856774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative serum pharmacokinetics of the fluoroquinolones enrofloxacin, difloxacin, marbofloxacin, and orbifloxacin in dogs after single oral administration.
    Heinen E
    J Vet Pharmacol Ther; 2002 Feb; 25(1):1-5. PubMed ID: 11874520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma and interstitial fluid pharmacokinetics of enrofloxacin, its metabolite ciprofloxacin, and marbofloxacin after oral administration and a constant rate intravenous infusion in dogs.
    Bidgood TL; Papich MG
    J Vet Pharmacol Ther; 2005 Aug; 28(4):329-41. PubMed ID: 16050812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraocular pharmacokinetics of intravenously administered marbofloxacin in rabbits with experimentally induced acute endophthalmitis.
    Regnier A; Schneider M; Concordet D; Toutain PL
    Am J Vet Res; 2008 Mar; 69(3):410-5. PubMed ID: 18312141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic evaluation of enrofloxacin in chickens.
    Abd el-Aziz MI; Aziz MA; Soliman FA; Afify NA
    Br Poult Sci; 1997 May; 38(2):164-8. PubMed ID: 9158891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of water deprivation on the disposition kinetics of enrofloxacin in camels.
    Gavrielli R; Yagil R; Ziv G; Creveld CV; Glickman A
    J Vet Pharmacol Ther; 1995 Oct; 18(5):333-9. PubMed ID: 8587150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-dose pharmacokinetics of marbofloxacin in Egyptian buffalo (Bubalus bubalis L.) steers.
    Goudah A; Abd El-Aty AM; Regmi NL; Shin HC; Shimoda M; Shim JH
    Berl Munch Tierarztl Wochenschr; 2007; 120(5-6):215-20. PubMed ID: 17555042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma concentrations of enrofloxacin and its active metabolite ciprofloxacin in dogs following single oral administration of enrofloxacin at 7.5, 10, or 20 mg/kg.
    Boothe DM; Boeckh A; Boothe HW; Wilkie S; Jones S
    Vet Ther; 2002; 3(4):409-19. PubMed ID: 12584678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.